Published in Trends Parasitol on June 01, 2003
Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis. Am J Trop Med Hyg (2006) 1.93
Strategies for detection of Plasmodium species gametocytes. PLoS One (2013) 1.67
Malaria vector control: from past to future. Parasitol Res (2011) 1.53
Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea. PLoS Negl Trop Dis (2011) 1.47
Multilocus haplotypes reveal variable levels of diversity and population structure of Plasmodium falciparum in Papua New Guinea, a region of intense perennial transmission. Malar J (2010) 1.47
Ownership and usage of mosquito nets after four years of large-scale free distribution in Papua New Guinea. Malar J (2012) 1.45
Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. PLoS One (2007) 1.45
Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots. Malar J (2010) 1.23
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial. PLoS Med (2012) 1.20
Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy. Malar J (2009) 1.14
A Large Plasmodium vivax Reservoir and Little Population Structure in the South Pacific. PLoS One (2013) 1.07
High Rates of Asymptomatic, Sub-microscopic Plasmodium vivax Infection and Disappearing Plasmodium falciparum Malaria in an Area of Low Transmission in Solomon Islands. PLoS Negl Trop Dis (2015) 1.07
Micro-geographic risk factors for malarial infection. Malar J (2009) 1.06
Seeking treatment for symptomatic malaria in Papua New Guinea. Malar J (2010) 1.00
Malaria case management in Papua New Guinea prior to the introduction of a revised treatment protocol. Malar J (2012) 0.99
Plasmodium vivax populations are more genetically diverse and less structured than sympatric Plasmodium falciparum populations. PLoS Negl Trop Dis (2015) 0.98
A qPCR-based multiplex assay for the detection of Wuchereria bancrofti, Plasmodium falciparum and Plasmodium vivax DNA. Trans R Soc Trop Med Hyg (2008) 0.97
Plasmodium vivax Diversity and Population Structure across Four Continents. PLoS Negl Trop Dis (2015) 0.96
Molecular-based assay for simultaneous detection of four Plasmodium spp. and Wuchereria bancrofti infections. Am J Trop Med Hyg (2010) 0.94
Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New Guinea. Malar J (2007) 0.94
Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study. PLoS Med (2012) 0.94
Research challenges and gaps in malaria knowledge in Papua New Guinea. Acta Trop (2011) 0.92
Pyrethroid susceptibility in natural populations of the Anopheles punctulatus group (Diptera: Culicidae) in Papua New Guinea. Am J Trop Med Hyg (2010) 0.92
Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers. Br J Clin Pharmacol (2008) 0.91
Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance. Malar J (2010) 0.91
Malaria--a major health problem within an oil palm plantation around Popondetta, Papua New Guinea. Malar J (2009) 0.88
Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether. Antimicrob Agents Chemother (2011) 0.88
Improving health worker adherence to malaria treatment guidelines in Papua New Guinea: feasibility and acceptability of a text message reminder service. PLoS One (2013) 0.87
Predictors of acute bacterial meningitis in children from a malaria-endemic area of Papua New Guinea. Am J Trop Med Hyg (2012) 0.85
Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea. Bull World Health Organ (2011) 0.84
Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population. Malar J (2008) 0.84
Ethical challenges in integrating patient-care with clinical research in a resource-limited setting: perspectives from Papua New Guinea. BMC Med Ethics (2013) 0.84
Tackling the malaria problem in the South-East Asia Region: need for a change in policy? Indian J Med Res (2013) 0.82
Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria. Antimicrob Agents Chemother (2013) 0.82
Multiplex assay for species identification and monitoring of insecticide resistance in Anopheles punctulatus group populations of Papua New Guinea. Am J Trop Med Hyg (2012) 0.82
Population hemoglobin mean and anemia prevalence in Papua New Guinea: new metrics for defining malaria endemicity? PLoS One (2010) 0.80
Time trend of malaria in relation to climate variability in Papua New Guinea. Environ Health Toxicol (2016) 0.80
Diversity of Plasmodium falciparum chloroquine resistance transporter (pfcrt) exon 2 haplotypes in the Pacific from 1959 to 1979. PLoS One (2012) 0.80
Malaria transmission dynamics surrounding the first nationwide long-lasting insecticidal net distribution in Papua New Guinea. Malar J (2016) 0.79
Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea. Malar J (2015) 0.79
Knowledge, attitudes, and practices concerning malaria in pregnancy: results from a qualitative study in Madang, Papua New Guinea. PLoS One (2015) 0.79
Changes in malaria burden and transmission in sentinel sites after the roll-out of long-lasting insecticidal nets in Papua New Guinea. Parasit Vectors (2016) 0.79
Malaria epidemiology in Lihir Island, Papua New Guinea. Malar J (2013) 0.77
Hyperuricaemia in the Pacific: why the elevated serum urate levels? Rheumatol Int (2013) 0.77
Effects of Plasmodium falciparum infection on umbilical artery resistance and intrafetal blood flow distribution: a Doppler ultrasound study from Papua New Guinea. Malar J (2017) 0.75
A Toll-like receptor-1 variant and its characteristic cellular phenotype is associated with severe malaria in Papua New Guinean children. Genes Immun (2015) 0.75
Plasticity of host selection by malaria vectors of Papua New Guinea. Parasit Vectors (2017) 0.75
Associations between malaria and local and global climate variability in five regions in Papua New Guinea. Trop Med Health (2016) 0.75
The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New Guinea. Elife (2017) 0.75
Cause-specific mortality rates in sub-Saharan Africa and Bangladesh. Bull World Health Organ (2006) 4.12
Child survival gains in Tanzania: analysis of data from demographic and health surveys. Lancet (2008) 4.03
Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science (2003) 3.59
An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis (2005) 3.25
Mapping malaria transmission in West and Central Africa. Trop Med Int Health (2006) 3.02
Lymphatic filariasis and onchocerciasis. Lancet (2010) 2.75
A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc Natl Acad Sci U S A (2003) 2.19
Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med (2007) 1.95
Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum. Am J Trop Med Hyg (2006) 1.86
Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities. Lancet (2010) 1.85
Estimating the duration of Plasmodium falciparum infection from trials of indoor residual spraying. Am J Trop Med Hyg (2004) 1.71
Tackling malaria today. BMJ (2008) 1.70
Host population persistence in the face of introduced vector-borne diseases: Hawaii amakihi and avian malaria. Proc Natl Acad Sci U S A (2005) 1.59
Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana. PLoS Med (2007) 1.56
Evaluation and application of modularly assembled zinc-finger nucleases in zebrafish. Development (2011) 1.54
Age-acquired immunity to a Plasmodium vivax invasion ligand, the duffy binding protein. J Infect Dis (2002) 1.53
ImmPort: disseminating data to the public for the future of immunology. Immunol Res (2014) 1.48
Antigenic drift in the ligand domain of Plasmodium vivax duffy binding protein confers resistance to inhibitory antibodies. J Infect Dis (2004) 1.40
Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis. BMC Biol (2010) 1.38
Onchocerciasis Control: Vision for the Future from a Ghanian perspective. Parasit Vectors (2009) 1.33
Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans. J Immunol (2002) 1.22
Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein. Infect Immun (2003) 1.21
A point mutation in codon 76 of pfcrt of P. falciparum is positively selected for by Chloroquine treatment in Tanzania. Infect Genet Evol (2002) 1.21
Clonal groupings in serogroup X Neisseria meningitidis. Emerg Infect Dis (2002) 1.20
Strain-specific humoral response to a polymorphic malaria vaccine. Infect Immun (2004) 1.18
Detectability of Plasmodium falciparum clones. Malar J (2010) 1.17
Molecular monitoring in malaria vaccine trials. Trends Parasitol (2003) 1.15
The added value of claims for cancer surveillance: results of varying case definitions. Med Care (2005) 1.14
Emergence of W135 meningococcal meningitis in Ghana. Trop Med Int Health (2005) 1.11
Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria. Antimicrob Agents Chemother (2004) 1.10
A six year retrospective review of occipital nerve stimulation practice--controversies and challenges of an emerging technique for treating refractory headache syndromes. J Headache Pain (2013) 1.09
An immigration-death model to estimate the duration of malaria infection when detectability of the parasite is imperfect. Stat Med (2005) 1.09
Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection. Malar J (2009) 1.09
Does radical cure of asymptomatic Plasmodium falciparum place adults in endemic areas at increased risk of recurrent symptomatic malaria? Trop Med Int Health (2002) 1.06
Nigeria Anopheles vector database: an overview of 100 years' research. PLoS One (2011) 1.05
The distribution of Plasmodium falciparum infection durations. Epidemics (2011) 1.04
Distinct Notch signaling outputs pattern the developing arterial system. Development (2014) 1.02
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma. Clin Cancer Res (2004) 1.02
Doc, shouldn't we be getting some tests? J Clin Oncol (2003) 1.01
Improved mapping strategy to better inform policy on the control of schistosomiasis and soil-transmitted helminthiasis in Sierra Leone. Parasit Vectors (2011) 0.98
Antigenic cross-reactivity between different alleles of the Plasmodium falciparum merozoite surface protein 2. Parasite Immunol (2004) 0.95
Regenerative medicine as applied to general surgery. Ann Surg (2012) 0.92
Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity. Infect Genet Evol (2006) 0.92
Effects of rifampin and ketoconazole on the pharmacokinetics of nilotinib in healthy participants. J Clin Pharmacol (2010) 0.92
Assessment of positivity in immuno-assays with variability in background measurements: a new approach applied to the antibody response to Plasmodium falciparum MSP2. J Immunol Methods (2002) 0.91
The challenge to avoid anti-malarial medicine stock-outs in an era of funding partners: the case of Tanzania. Malar J (2014) 0.90
High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea. Infect Genet Evol (2010) 0.88
Launch of the international podoconiosis initiative. Lancet (2012) 0.86
Complex patterns of malaria epidemiology in the highlands region of Papua New Guinea. P N G Med J (2003) 0.85
Cardiopulmonary resuscitation: attitudes and perceptions of junior doctors. Hosp Med (2003) 0.84
Repair of peripheral nerve defects in rabbits using keratin hydrogel scaffolds. Tissue Eng Part A (2011) 0.83
The end-of-life experience for a cohort of patients with pulmonary arterial hypertension. J Palliat Med (2012) 0.81
The use of 10-kilohertz spinal cord stimulation in a cohort of patients with chronic neuropathic limb pain refractory to medical management. Neuromodulation (2014) 0.81
Stochastic simulation of endemic Salmonella enterica serovar Typhi: the importance of long lasting immunity and the carrier state. PLoS One (2013) 0.81
Effectively starting and titrating intrathecal analgesic therapy in patients with refractory cancer pain. Clin J Oncol Nurs (2005) 0.81
Flexible couplings: diffusing neuromodulators and adaptive robotics. Artif Life (2005) 0.80
Maternal malaria during pregnancy and infant mortality rate: critical literature review and a new analytical approach. J Vector Borne Dis (2007) 0.80
Lead exposure in Mexican radiator repair workers. Am J Ind Med (2002) 0.78
Supported liquid extraction in combination with LC-MS/MS for high-throughput quantitative analysis of hydrocortisone in mouse serum. Biomed Chromatogr (2010) 0.78
Predictors of attention problems for the period from pre-teen to early teen years. Psychopathology (2006) 0.77
Calcification after myocardial infarction is independent of amniotic fluid stem cell injection. Cardiovasc Pathol (2010) 0.77
Attention problems among children with a positive family history of alcohol abuse or dependence and controls. Prevalence and course for the period from preteen to early teen years. Eur Addict Res (2007) 0.77
Human metapneumovirus infection in South African children hospitalised with respiratory tract disease. S Afr Med J (2004) 0.77
Sensitivity and specificity of ultrasound detection and risk factors for filarial-associated hydroceles. Am J Trop Med Hyg (2003) 0.77
Dyadic adjustment, family coping, body image, quality of life and psychological morbidity in patients with psoriasis and their partners. Int J Behav Med (2012) 0.76
Aspirin for the next generation. Ecancermedicalscience (2013) 0.75
Early stages of insulin fibrillogenesis examined with ion mobility mass spectrometry and molecular modelling. Analyst (2015) 0.75
Picture this: the state of the art in visualization for complex adaptive systems. Artif Life (2006) 0.75
The value of a writing center at a medical university. Teach Learn Med (2013) 0.75
Development of a microportable imaging system for otoscopy and nasoendoscopy evaluations. Cleft Palate Craniofac J (2007) 0.75
From conception to delivery. Frontline Gastroenterol (2010) 0.75
Using incident reporting to design authentic interprofessional education. Med Educ (2015) 0.75